Technetium-99m DTPA localized in gynecomastia secondary to orchiectomy and estrogen therapy in a patient with carcinoma of the prostate.
Shih
W J
WJ
Veterans Administration Medical Center, Nuclear Medicine Service, Lexington, Kentucky 40536-0084.
Wierzbinski
B
B
Magoun
S
S
Ryo
U Y
UY
D000368:Aged; D003131:Combined Modality Therapy; D004966:Estrogens, Conjugated (USP) / Q000009:adverse effects* / Q000627:therapeutic use; D006177:Gynecomastia / Q000000981:diagnostic imaging* / Q000209:etiology; D006801:Humans; D008297:Male; D009919:Orchiectomy / Q000009:adverse effects*; D009942:Organometallic Compounds; D004369:Pentetic Acid; D011471:Prostatic Neoplasms / Q000628:therapy*; D011877:Radionuclide Imaging; D013667:Technetium; D016284:Technetium Tc 99m Pentetate
D004966:Estrogens, Conjugated (USP); D009942:Organometallic Compounds; D013667:Technetium; D004369:Pentetic Acid; D016284:Technetium Tc 99m Pentetate